Amy Zhou

Amy is an experienced life sciences strategy consultant with areas of expertise including pricing and market access, launch readiness and brand strategy, focusing on issues within brands as well as across the portfolio. Amy has worked in a wide range of therapeutic areas including cardiovascular disease, oncology, infectious diseases, and orphan indications.

Prior to joining CRA, Amy was a manager at QuintilesIMS (IQVIA), where she was an experienced project manager of global client engagements.

Amy has extensive experience project managing global pricing and market access engagements including cross-portfolio strategy and indication prioritization.